Minicell-based transformation
AssigneeNone recorded
InventorsRoger A. Sabbadini, Neil Berkley, Mark W. Surber
Life of this patent
Estimating the term…
Abstract
The invention provides compositions and methods for the production of achromosomal and anucleate cells useful for applications such as diagnositic and therapeutic uses, as well as research tools and agents for drug discovery.
Drawings
Claims20
A minicell comprising at least one nucleic acid, wherein said minicell displays a binding moiety directed to a target compound, wherein said binding moiety is selected from the group consisting of (i) a eukaryotic membrane protein;
- (ii) an archeabacterial membrane protein;
- (iii) an organellar membrane protein;
- and (iv) a fusion protein, said fusion protein comprising a first polypeptide, said first polypeptide comprising at least one transmembrane domain or at least one membrane anchoring domain;
- and a second polypeptide, wherein said second polypeptide is not derived from a eubacterial protein and is neither a His tag nor a glutathione-S-transferase polypeptide, and wherein said polypeptide comprises a binding moeity.
A method of introducing a nucleic acid into a cell, comprising contacting said cell with a minicell that comprises said nucleic acid, wherein said minicell displays a binding moiety, wherein said binding moiety is selected from the group consisting of (i) a eukaryotic membrane protein;
- (ii) an archeabacterial membrane protein;
- (iii) an organellar membrane protein;
- and (iv) a fusion protein, said fusion protein comprising a first polypeptide, said first polypeptide comprising at least one transmembrane domain or at least one membrane anchoring domain;
- and a second polypeptide, wherein said second polypeptide is not derived from a eubacterial protein and is neither a His tag nor a glutathione-S-transferase polypeptide, and wherein said polypeptide comprises a binding moiety;
- and wherein said binding moiety binds an epitope of said cell.
Dependencies are inferred from the claim text.